The Controlant Saga Card employs low power nRF9160 SiP to record event and location data and report it to the Cloud so medicines and vaccines reach patients safely, and waste is eliminated
Controlant, a global leader in the digital transformation of pharmaceutical supply chains, has announced an asset tracking device enabling end-to-end supply chain visibility at the asset or unit level from the time of packing to the point of use. The ‘Saga Card’ is an advanced IoT device that integrates Nordic Semiconductor’s nRF9160 SiP to provide monitoring of cases, cartons, and secondary packaging of medicines and vaccines.
When combined with Controlant’s ‘Aurora’ Cloud platform, it can provide ‘real time’ inventory visibility at country, region, and city level to pharma companies, logistics companies serving the pharma industry, and providers of temperature-controlled packaging solutions. This enables pharma supply chains of the future to deliver increasingly complex and sensitive medicines and vaccines to people around the world, while reducing waste.
“Saga Card is an innovation designed to enable pharma supply chains to deliver today’s and tomorrow’s transformative medicines, including complex new treatments, to patients around the world, safely and sustainably,” says Gisli Herjolfsson, CEO and co-founder of Controlant.
